Pipeline

  • Compound
  • Developmental Focus
  • Discovery Research
  • Preclinical
  • Phase I
    • MAB BV-15, BV-27, BV-06,
      BV-12
    • Oncology
    • Patent app filed with uspto
      mab characterization studies are ongoing
    • Peptides OFA-1, OFA-2, OFA-3
    • Acute Myeloid Leukemia (AML)
      Multiple Myeloma (MM)
      Myelodysplastic Syndrome (MDS)
    • Fda authorized
      phase i study
      Clinical Trial
      Information